幽门螺杆菌根除后使用SSRI的上消化道出血住院风险:倾向性评分匹配分析
本研究基于香港全港医疗数据库,纳入接受幽门螺杆菌根除治疗后使用SSRI的患者,采用倾向性评分1:2匹配及Cox回归分析。结果显示SSRI使用者非静脉曲张性上消化道出血住院风险显著升高(HR 1.95,95%CI 1.41-2.70),且风险增加仅见于50岁以上患者。
要点
- 幽门螺杆菌根除后使用SSRI仍与上消化道出血住院风险升高相关(HR 1.95)。
- 风险增加仅在50岁以上患者中显著。
- 临床对老年SSRI使用者应警惕上消化道出血风险。
核心结论
- 幽门螺杆菌根除治疗后使用SSRI者非静脉曲张性上消化道出血住院风险仍较高,尤其50岁以上患者。
研究设计与样本
- 采用1:2倾向性评分匹配及Cox回归模型计算风险比(HR)和95%CI。
主要发现
- 中位随访7.74年(IQR 5.32-10.42),上消化道出血住院粗发生率为3.98/1000人年(95%CI 3.80-4.16)。
- 1:2匹配分析中,SSRI使用者上消化道出血风险高于非使用者(HR 1.95,95%CI 1.41-2.70)。
- 1:1匹配敏感性分析(HR 2.13,95%CI 1.50-3.02)及多变量分析1个月间隔(HR 1.81,95%CI 1.34-2.45)、3个月间隔(HR 1.61,95%CI 1.20-2.17)结果一致。
- 按年龄分层后,SSRI相关风险增加仅在50岁以上患者中显著。
临床怎么用
- 对幽门螺杆菌根除后使用SSRI的患者,尤其是50岁以上者,应关注上消化道出血风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for depression but there is a concern about the risk of upper gastrointestinal bleeding (UGIB). Past studies, however, are largely confounded by the presence of Helicobacter pylori (HP). AIM: To evaluate the UGIB risk of SSRI users after treatment for HP. METHODS: This was a propensity score (PS) matched cohort study with patients who used SSRI after receiving HP eradication therapy from the Hong Kong territory-wide healthcare database. The primary outcome was hospitalisation for nonvariceal UGIB. PS matching analysis with a ratio of 1:2 plus Cox regression model was used to compute the hazards ratios (HR) and 95% CI of UGIB risk. RESULTS: In this study, 3358 SSRI users and 57 906 non-users were included. The median follow-up duration was 7.74 (interquartile range 5.32-10.42) years. The crude incidence of hospitalisation for UGIB was 3.98 (95% CI 3.80-4.16) per 1000 person-years. In the PS matching analysis of 3358 SSRI users with 6716 non-users, SSRI was associated with a higher risk of UGIB compared to non-users (HR 1.95, 95% CI 1.41-2.70). This result was consistent in sensitivity analysis with 1:1 PS matching (HR 2.13, 95% CI 1.50-3.02) and multivariable analysis with 1-month intervals (HR 1.81, 95% CI 1.34-2.45) or 3-month intervals (HR 1.61, 95% CI 1.20-2.17). After stratifying by age, the increased risk of SSRI was only significant among patients >50 years. CONCLUSION: SSRI users have a higher risk of hospitalisation for nonvariceal UGIB after treatment for HP, particularly among older patients.
引用
- Guo CG, Cheung KS, Zhang F, et al. Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis. Aliment Pharmacol Ther. 2019. PMID: 31583734. doi:10.1111/apt.15507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。